Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils

Gut Microbes. 2022 Jan-Dec;14(1):2073785. doi: 10.1080/19490976.2022.2073785.

Abstract

Intratumor microbiome shapes the immune system and influences the outcome of various tumors. Porphyromonas gingivalis (P. gingivalis), the keystone periodontal pathogen, is highly epidemically connected with pancreatic cancer (PC). However, its causative role and the underlining mechanism in promoting PC oncogenesis remain unclear. Here, we illustrated the landscape of intratumor microbiome and its bacterial correlation with oral cavity in PC patients, where P. gingivalis presented both in the oral cavity and tumor tissues. When exposed to P. gingivalis, tumor development was accelerated in orthotopic and subcutaneous PC mouse model, and the cancerous pancreas exhibited a neutrophils-dominated proinflammatory tumor microenvironment. Mechanistically, the intratumoral P. gingivalis promoted PC progression via elevating the secretion of neutrophilic chemokines and neutrophil elastase (NE). Collectively, our study disclosed the bacterial link between periodontitis and PC, and revealed a previously unrecognized mechanism of P. gingivalis in PC pathophysiology, hinting at therapeutic implications.

Keywords: Pancreatic cancer; Porphyromonas gingivalis; inflammation; neutrophil; neutrophil elastase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinogenesis
  • Cell Transformation, Neoplastic
  • Gastrointestinal Microbiome*
  • Humans
  • Leukocyte Elastase
  • Mice
  • Neutrophils
  • Pancreas
  • Periodontitis* / microbiology
  • Porphyromonas gingivalis
  • Tumor Microenvironment

Substances

  • Leukocyte Elastase

Grants and funding

This work was supported by Disciplines Construction Project [Grant No 201920202103]; CAMS Innovation Fund for Medical Sciences (CIFMS) [Grant No 2021-I2M-1-050]; National Natural Science Foundation of China [Grant No 82003264, 51972343 and 51937011]; CAMS Innovation Fund for Medical Sciences (CIFMS) [Grant No 2021-I2M-1-066]; Beijing Hospital Project [Grant No BJ-2019-134]; Friendship Seed Program [YYZZ202019].